
Leo Pharma on Monday said its drug to treat inflammatory skin condition has received scientific approval in the European Union. …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

